Breast Cancer Research
Our Research
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks estrogen, progesterone, and HER2 receptors, making it resistant to many conventional targeted therapies. Traditionally, chemotherapy has been the main treatment option for TNBC, but it often comes with high recurrence rates and significant side effects.